Head to Head Survey: Nanovibronix (FEED) & Its Competitors

Nanovibronix (NASDAQ:FEED) is one of 28 publicly-traded companies in the “Surgical, Medical, And Dental Instruments And Supplies” industry, but how does it weigh in compared to its competitors? We will compare Nanovibronix to similar companies based on the strength of its profitability, analyst recommendations, earnings, valuation, institutional ownership, dividends and risk.

Risk and Volatility

Nanovibronix has a beta of 2.21, indicating that its stock price is 121% more volatile than the S&P 500. Comparatively, Nanovibronix’s competitors have a beta of 1.76, indicating that their average stock price is 76% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current recommendations and price targets for Nanovibronix and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nanovibronix	1	0	0	0	1.00
Nanovibronix Competitors	77	78	155	6	2.28

As a group, “Surgical, Medical, And Dental Instruments And Supplies” companies have a potential upside of 32.53%. Given Nanovibronix’s competitors stronger consensus rating and higher probable upside, analysts plainly believe Nanovibronix has less favorable growth aspects than its competitors.

Institutional & Insider Ownership

16.4% of Nanovibronix shares are owned by institutional investors. Comparatively, 19.3% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are owned by institutional investors. 1.4% of Nanovibronix shares are owned by company insiders. Comparatively, 19.5% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Nanovibronix and its competitors gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Nanovibronix	$2.56 million	-$3.70 million	-0.05
Nanovibronix Competitors	$60.44 million	-$32.15 million	5.39

Nanovibronix’s competitors have higher revenue, but lower earnings than Nanovibronix. Nanovibronix is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Nanovibronix and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nanovibronix	-275.12%	-24.78%	-19.24%
Nanovibronix Competitors	-672.41%	-133.75%	-59.01%

Summary

Nanovibronix competitors beat Nanovibronix on 8 of the 13 factors compared.

Nanovibronix Company Profile

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.